Four of the 11 genes (CDC20, CEP55, FOXM1 and MELK) had lower expression levels in BC patients with pCR, while the remaining genes were up-regulated in BC patients with pCR (Fig. 5B). This evidence concerns the gene CDC20 and breast cancer.